[EN] SUBSTITUTED 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES FOR THE TREATMENT OF SARCOMA<br/>[FR] 3,6-DIHYDRO-2H-1,3,4-OXADIAZIN-2-ONES SUBSTITUÉES POUR LE TRAITEMENT DU SARCOME
申请人:[en]BAYER AKTIENGESELLSCHAFT
公开号:WO2022184748A1
公开(公告)日:2022-09-09
The present invention provides a method of treatment of sarcoma comprising administering to a patient in need thereof a compound of general formula (I),, formula (I) in which R1, R2, R3, and R4, are as defined herein, alone or in pharmaceutical compositions or combinations comprising said compounds as a sole agent or in combination with other active ingredients.